WX8:FRA
WuXi AppTec Ord Shs H
€23.49
0.00%
(0.00) 1D
Oct 12, 3:25:01 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for WX8...
Mkt. cap
565.25B
Avg. vol.
75.00
Volume
0.00
52-wk high
€25.00
52-wk low
€10.60
No. of employees
36K
Mkt. cap
565.25B
Avg. vol.
75.00
Volume
0.00
52-wk high
€25.00
52-wk low
€10.60
No. of employees
36K
News stories
From web sources and news partners
ad-hoc-news.de
·
17 hours ago
WuXi AppTec stock at EUR 23.68, volume 45.2 percent below average
ad-hoc-news.de
·
21 hours ago
WuXi AppTec raises guidance while WuXi AppTec stock costs EUR 23.63
TipRanks
·
21 hours ago
WuXi AppTec Sets October Board Meeting to Approve Q3 2026 Results
ad-hoc-news.de
·
1 day ago
WuXi AppTec stock pre-market at EUR 23.67
Profile
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
About WuXi AppTec Ord Shs H
CEOSteve Yang | Ge Li
Employees35.6K
FoundedDec 1, 2000
Headquarters-
SectorHealth care
Websitewuxiapptec.com.cn